LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 73 filers reported holding LOXO ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $29,012,000 | -17.9% | 207,124 | +0.2% | 0.02% | -8.3% |
| Q3 2018 | $35,324,000 | +57.8% | 206,778 | +60.3% | 0.02% | +50.0% |
| Q2 2018 | $22,382,000 | +74.8% | 129,016 | +16.3% | 0.02% | +60.0% |
| Q1 2018 | $12,804,000 | +40.8% | 110,975 | +2.7% | 0.01% | +42.9% |
| Q4 2017 | $9,093,000 | -6.7% | 108,015 | +2.2% | 0.01% | -22.2% |
| Q3 2017 | $9,741,000 | +48.6% | 105,741 | +29.4% | 0.01% | +50.0% |
| Q2 2017 | $6,553,000 | +110.7% | 81,716 | +10.6% | 0.01% | +100.0% |
| Q1 2017 | $3,110,000 | +123.3% | 73,892 | +70.4% | 0.00% | +50.0% |
| Q4 2016 | $1,393,000 | +29.6% | 43,359 | +5.6% | 0.00% | +100.0% |
| Q3 2016 | $1,075,000 | +124.9% | 41,049 | +99.3% | 0.00% | 0.0% |
| Q2 2016 | $478,000 | +32.4% | 20,600 | +56.1% | 0.00% | – |
| Q1 2016 | $361,000 | -4.0% | 13,200 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $376,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |